| Net Cash Provided by (Used in) Operating Activities |
$101,482,000 |
USD |
4.8% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$2,106,096,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$2,090,272,000 |
USD |
-1269% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
175,000,000 |
shares |
40% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
111,898,000 |
shares |
103% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$117,306,000 |
USD |
17701% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$308,520,000 |
USD |
56% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$132,272,000 |
USD |
-3.3% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$14,394,000 |
USD |
74% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$257,341,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
6,847,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$5,441,809,000 |
USD |
22% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
6,847,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |